About Massive Bio
Massive Bio is a company based in New York (United States) founded in 2014. Massive Bio has raised $14.13 million across 4 funding rounds from investors including ImpactAssets, Revo Capital and Kenan Turnacioglu. Massive Bio operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.13 M (USD)
in 4 rounds
-
Latest Funding Round
$9 M (USD), Series B
Jun 02, 2022
-
Investors
ImpactAssets
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Massive Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Massive Bio
Massive Bio has successfully raised a total of $14.13M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Massive Bio
Massive Bio has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include ImpactAssets, Revo Capital and Kenan Turnacioglu.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by Revo Capital toward Turkey-based startups.
|
Locked | Locked | Locked | |
|
Private equity firm focused on growth equities
|
Locked | Locked | Locked | |
|
Tech focused corporate VC firm investing in early stage startups in Turkey
|
Locked | Locked | Locked |
Investor details for Massive Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Massive Bio
Investment portfolio details for Massive Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Massive Bio
Detailed financials for Massive Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Massive Bio Comparisons
Peer comparison for Massive Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Massive Bio
Massive Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
Detailed competitors of Massive Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Massive Bio
Complete news archive for Massive Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Massive Bio
Massive Bio was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Massive Bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Massive Bio is a funded company, having raised a total of $14.13M across 4 funding rounds to date.
Massive Bio was founded in 2014 and is headquartered in New York, United States. Operations center on the healthcare technology sector, where AI-driven platforms are utilized for clinical trial management. Services encompass real-time patient identification, trial matching, ongoing monitoring, and coordination assistance. Full-stack engineering solutions are employed to support efficient trial processes across various locations.
Massive Bio has 5 investors. Key investors include ImpactAssets, Revo Capital, Kenan Turnacioglu, DEG, and 500 Istanbul.